This site is intended for healthcare professionals
Improving outcomes in AL amyloidosis, Human kidney. Amyloidosis, Congo red

Improving outcomes in AL amyloidosis

Supported by Alexion
Last updated: 3rd Dec 2024
Published:15th Sep 2023

These pages are for healthcare professionals seeking information about AL amyloidosis, and feature expert advice on best-practice management of this disease.

  • Make your own decisions in an interactive patient journey, hosted by Dr Shaji Kumar
  • Review highlights from the European Society of Cardiology 2023 Congress, covering cardiac dysfunction and the benefits of multidisciplinary care, with expert comment from Professor Stefano Perlini
  • Consider takeaways from the International Symposium on Amyloidosis, including managing comorbidities, screening tools, and emerging treatments, with Professor Giovanni Palladini
  • Take in details from the experts about symptoms, diagnosis and treatment, and the patient’s perspective on what it is like to be diagnosed with AL amyloidosis, from our series of four podcasts
Welcome:

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information 

 

By providing your email address, you are opting in to receive our monthly newsletter.

We will never share your data, and you can withdraw consent at any time. Read our privacy policy here.

Developed independently by EPG Health, which received an educational grant from Alexion, awarded to EPG Health to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.